ADRXVSRCL• 3 Months (Normalized)
ADRX vs RCL (ADARx Pharmaceuticals Inc. vs Royal Caribbean Cruises Ltd.)
Showing Closing Date Range from Jul 9 to Oct 7, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ADRX Performance $17.33
-10.44%
ADARx Pharmaceuticals Inc.
Normalized Baseline0.00%
RCL Performance $282.35
-1.99%
Royal Caribbean Cruises Ltd.
Normalized Baseline0.00%
Alpha Spread Margin RCL LEADS
-8.45 pts
RCL outperforming by 8.45 percentage points
ADRXRCL
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ADRX RCL
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(64 dates)
| Date | ADRX Price | ADRX Gain (%) | RCL Price | RCL Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 07, 2026 | $17.33 | -10.44% | $282.35 | -1.99% | -8.45% |
| Oct 06, 2026 | $18.58 | -3.98% | $288.84 | +0.26% | -4.24% |
| Oct 05, 2026 | $19.05 | -1.55% | $275.16 | -4.48% | +2.93% |
| Oct 02, 2026 | $18.25 | -5.68% | $277.74 | -3.59% | -2.09% |
| Oct 01, 2026 | $- | $269.99 | -6.28% | - | |
| Sep 30, 2026 | $- | $265.86 | -7.71% | - | |
| Sep 29, 2026 | $20.64 | +6.67% | $260.67 | -9.51% | +16.18% |
| Sep 28, 2026 | $20.09 | +3.82% | $242.59 | -15.79% | +19.61% |
| Sep 25, 2026 | $19.35 | +0.00% | $242.70 | -15.75% | +15.75% |
| Sep 24, 2026 | $- | $238.98 | -17.04% | - | |
| Sep 23, 2026 | $- | $230.30 | -20.06% | - | |
| Sep 22, 2026 | $- | $234.89 | -18.46% | - | |
| Sep 21, 2026 | $- | $250.25 | -13.13% | - | |
| Sep 18, 2026 | $- | $245.81 | -14.67% | - | |
| Sep 17, 2026 | $- | $249.74 | -13.31% | - |
Page 1 of 5